Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C27H33N2.HO4S |
| Molecular Weight | 482.635 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS([O-])(=O)=O.CCN(CC)C1=CC=C(C=C1)C(C2=CC=CC=C2)=C3C=CC(C=C3)=[N+](CC)CC
InChI
InChIKey=NNBFNNNWANBMTI-UHFFFAOYSA-M
InChI=1S/C27H33N2.H2O4S/c1-5-28(6-2)25-18-14-23(15-19-25)27(22-12-10-9-11-13-22)24-16-20-26(21-17-24)29(7-3)8-4;1-5(2,3)4/h9-21H,5-8H2,1-4H3;(H2,1,2,3,4)/q+1;/p-1
| Molecular Formula | HO4S |
| Molecular Weight | 97.071 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C27H33N2 |
| Molecular Weight | 385.5643 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Bacteial cells growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/13416511 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | BRILLIANT GREEN Approved UseBrilliant green is used as antiseptic for skin abrasions and scratches; to mark the intended section place before the surgical operation. |
|||
| Preventing | KERR 100 TRIPLE DYE Approved UseAids in the prevention of infection in the umbilical cord area of newborn. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011-07-14 |
|
| Effect of brilliant green on the motility of Salmonellae and other selected microorganisms. | 1969-10 |
|
| EFFECT OF VARIOUS CONCENTRATIONS OF BRILLIANT GREEN AND BILE SALTS ON SALMONELLAE AND OTHER MICROORGANISMS. | 1965-01 |
|
| Use of crystal violet or brilliant green dyes for the determination of Salmonellae in dried food products. | 1960-12 |
|
| A Note on the Value of Brilliant Green as an Antiseptic. | 1917-06-30 |
Sample Use Guides
Apply to the affected area using cotton swabs or gauze pads.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13416511
Staphylococcus aureus strain was treated with brilliant green at final concentration of 8.8*10(-4) M. At this concentration the drug inhibited the cells growth by 50%.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:26:24 GMT 2025
by
admin
on
Mon Mar 31 21:26:24 GMT 2025
|
| Record UNII |
G0L543D370
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19698
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
Brilliant green (dye)
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
6403
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
88173
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
DTXSID1048700
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
633-03-4
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
C83560
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
4665
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
m2650
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
G0L543D370
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
211-190-1
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
C006798
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
DBSALT002749
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
SUB13121MIG
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
5011
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
100000092522
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
G0L543D370
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY | |||
|
12449
Created by
admin on Mon Mar 31 21:26:24 GMT 2025 , Edited by admin on Mon Mar 31 21:26:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |